Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.

[1]  A. Monto,et al.  Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. , 2016, The Journal of infectious diseases.

[2]  F. Pozo,et al.  Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014. , 2015, Vaccine.

[3]  L. Blumberg,et al.  Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014 , 2015, Influenza and other respiratory viruses.

[4]  D. Skowronski,et al.  Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. , 2015, The Journal of infectious diseases.

[5]  S. de Lusignan,et al.  Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  D. Skowronski,et al.  Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  Richard K. Zimmerman,et al.  Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[8]  H. Kelly,et al.  Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia. , 2015, Vaccine.

[9]  E. R. van den Heuvel,et al.  Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. , 2014, The Lancet. Infectious diseases.

[10]  Richard K. Zimmerman,et al.  Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.

[11]  Benjamin J Cowling,et al.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review , 2014, Expert review of vaccines.

[12]  G. Dowse,et al.  Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012. , 2014, Vaccine.

[13]  H. Kelly,et al.  Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  T. Friedrich,et al.  Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  P. Yang,et al.  Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. , 2014, Vaccine.

[16]  H. Kelly,et al.  Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  F. Pozo,et al.  Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. , 2014, Vaccine.

[18]  C Moore,et al.  Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  D. Skowronski,et al.  Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. , 2014, The Journal of infectious diseases.

[20]  N. Stocks,et al.  Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network , 2014, The Medical journal of Australia.

[21]  H. Kelly,et al.  Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: Influences of waning immunity and vaccine match , 2014, Journal of medical virology.

[22]  Jose L. Sanchez,et al.  Brief report: mid-season influenza vaccine effectiveness estimates for the 2013-2014 influenza season. , 2014, MSMR.

[23]  D. Skowronski,et al.  Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses , 2014, PloS one.

[24]  A. Monto,et al.  Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014 , 2014, MMWR. Morbidity and mortality weekly report.

[25]  F. Pozo,et al.  Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[26]  U. Buchholz,et al.  Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[27]  A. Monto,et al.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  C. Robertson,et al.  Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season. , 2013, Vaccine.

[29]  T. Vega,et al.  Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination , 2013, BMC Infectious Diseases.

[30]  H. Kelly,et al.  Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Michael Haber,et al.  The case test-negative design for studies of the effectiveness of influenza vaccine. , 2013, Vaccine.

[32]  Jennifer C Nelson,et al.  The test-negative design for estimating influenza vaccine effectiveness. , 2013, Vaccine.

[33]  E. Belongia,et al.  Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season. , 2013, The Journal of infectious diseases.

[34]  J. Castilla,et al.  Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study , 2013, BMC Public Health.

[35]  Wen-Ta Chiu,et al.  Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine-Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011−12 Season , 2013, PloS one.

[36]  J. Castilla,et al.  Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[37]  F. Pozo,et al.  Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[38]  M. Valenciano,et al.  Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[39]  D. Fleming,et al.  Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[40]  W. Hautmann,et al.  Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season , 2012, Epidemiology and Infection.

[41]  A. Monto,et al.  Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  D. Skowronski,et al.  Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. , 2012, The Journal of infectious diseases.

[43]  W Carman,et al.  Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom , 2012, Epidemiology and Infection.

[44]  F. Pozo,et al.  Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. , 2012, Vaccine.

[45]  D. Skowronski,et al.  A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  H. Kelly,et al.  Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[47]  C. Robertson,et al.  Assessment of the Variability in Influenza A(H1N1) Vaccine Effectiveness Estimates Dependent on Outcome and Methodological Approach , 2011, PloS one.

[48]  T. Vega,et al.  Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010 , 2011, BMC public health.

[49]  M. Valenciano,et al.  I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe , 2011, PloS one.

[50]  P. V. Van Caeseele,et al.  Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. , 2011, Vaccine.

[51]  S. Lindstrom,et al.  Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. , 2011, Vaccine.

[52]  A. Monto,et al.  Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities , 2011, PloS one.

[53]  J. Castilla,et al.  Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. , 2011, Vaccine.

[54]  H. Kelly,et al.  Effectiveness of Seasonal Influenza Vaccine against Pandemic (H1N1) 2009 Virus, Australia, 2010 , 2011, Emerging infectious diseases.

[55]  H. Kelly,et al.  Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008 , 2011, BMC infectious diseases.

[56]  Xiyan Xu,et al.  Serologic assays for influenza surveillance, diagnosis and vaccine evaluation , 2011, Expert review of anti-infective therapy.

[57]  J. Noh,et al.  Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. , 2011, Vaccine.

[58]  D. Skowronski,et al.  Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009 , 2011, BMJ : British Medical Journal.

[59]  H. Kelly,et al.  Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children: A Case–Control Study , 2011, The Pediatric infectious disease journal.

[60]  W Carman,et al.  Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[61]  M. Valenciano,et al.  Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study , 2011, PLoS medicine.

[62]  D M Fleming,et al.  Estimating influenza vaccine effectiveness using routinely collected laboratory data , 2009, Journal of Epidemiology & Community Health.

[63]  M. Valenciano,et al.  "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[64]  Yan Li,et al.  Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. , 2009, The Journal of infectious diseases.

[65]  D. Skowronski,et al.  Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. , 2007, Vaccine.

[66]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[67]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[68]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[69]  L. Simonsen,et al.  The impact of influenza epidemics on mortality: introducing a severity index. , 1997, American journal of public health.

[70]  N. Cox,et al.  Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. , 1994, The Journal of infectious diseases.

[71]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[72]  S. de Lusignan,et al.  Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[73]  Nicholas S. Kelley,et al.  Effi cacy and eff ectiveness of infl uenza vaccines: a systematic review and meta-analysis , 2012 .

[74]  K. Stöhr,et al.  Influenza virus surveillance, vaccine strain selection, and manufacture. , 2012, Methods in molecular biology.

[75]  Nicholas S. Kelley,et al.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[76]  Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. , 2005, Canada communicable disease report = Releve des maladies transmissibles au Canada.